Phase 2 Superficial Bladder Cancer Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Non-muscle Invasive Bladder Cancer With Carcinoma in SituSuperficial Bladder Cancer

enGene, Inc.350 enrolled101 locationsNCT04752722

Recruiting

Phase 2

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer

Bladder CancerSuperficial Bladder Cancer

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)49 enrolled3 locationsNCT03379909

Recruiting

Phase 2

Intravesical Gemcitabine

Superficial Bladder Cancer

St George Hospital, Kogarah90 enrolled1 locationACTRN12607000160437